Treatment of Children and Adolescents With Refractory or Relapsed Acute Myeloid Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00186966
Recruitment Status : Completed
First Posted : September 16, 2005
Last Update Posted : April 6, 2011
International BFM Study Group
St. Jude Children's Research Hospital
Information provided by:
Dutch Childhood Oncology Group

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : April 2009
  Actual Study Completion Date : September 2010
Publications of Results:
Kaspers J, Zimmermann M, Fleischhack G, Tamminga R, Gibson B, Armendariz H, Dworzak M, Ha S, Hovi L, Maschan A, Philippe N, Razzouk B, Rizzari C, Smisek P, Smith O, Stark B, Will A, Creutzig U. Relapsed Acute Myeloid Leukemia in Children and Adolescents: Interim Report of the International Randomised Phase III Study Relapsed AML 2001/01. 2006 ASH Annual Meeting Abstracts 108: 2013.